METHYL 4-METHYL-3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZOATE
METHYL 4-METHYL-3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZOATE Basic information
- Product Name:
- METHYL 4-METHYL-3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZOATE
- Synonyms:
-
- 5-Methoxycarbonyl-2-methylphenylboronic acid pinacol ester
- Benzoic acid, 4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, methyl ester
- METHYL 4-METHYL-3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZOATE
- Methyl4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl
- Methyl4-methyl-3-(4,4,5,5-tetramethyl-
- Methyl 4-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan
- 5-(Methoxycarbonyl)-2-methylphenylboronic acid pinacol ester, 95%,
- (3-hydroxy-2,3-dimethylbutan-2-yl)oxy-(5-methoxycarbonyl-2-methylphenyl)borinic acid
- CAS:
- 882679-40-5
- MF:
- C15H21BO4
- MW:
- 276.14
- Mol File:
- 882679-40-5.mol
METHYL 4-METHYL-3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZOATE Chemical Properties
- Boiling point:
- 383.1±35.0 °C(Predicted)
- Density
- 1.07±0.1 g/cm3(Predicted)
- storage temp.
- Inert atmosphere,2-8°C
- form
- solid
- Appearance
- White to off-white Solid
METHYL 4-METHYL-3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZOATE Usage And Synthesis
Synthesis
104901-43-1
73183-34-3
882679-40-5
General procedure for the synthesis of methyl 4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate from methyl 3-bromo-4-methylbenzoate and pinacol ester of biboronic acid: Methyl 3-bromo-4-methylbenzoate (3 mL, 19.2 mmol) was dissolved in 1,4-dioxane (96 mL), bis(pinacolato ) diboron (7.31 g, 28.2 mmol) and potassium acetate (5.65 g, 57.6 mmol) were added. Subsequently, Pd(dppf)Cl2 (2.8 g, 3.84 mmol) was added to the reaction system. The resulting mixture was stirred at 90 °C for 16 h under argon protection. After completion of the reaction, the mixture was cooled to room temperature and the reaction was quenched by the addition of water. The reaction mixture was extracted with ethyl acetate (EtOAc), the organic layers were combined and dried over anhydrous magnesium sulfate. The organic phase was concentrated under reduced pressure and purified by silica gel column chromatography to afford the target product methyl 4-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate (off-white solid, 4.46 g, 84% yield). The product was characterized by 1H NMR (300 MHz, CDCl3): δ 8.40 (d, 1H), 7.97 (dd, 1H), 7.23 (d, 1H), 3.94-3.87 (m, 3H), 2.58 (s, 3H), 1.35 (d, 12H).
References
[1] Chemical Communications, 2012, vol. 48, # 34, p. 4115 - 4117
[2] Patent: EP2963027, 2016, A1. Location in patent: Paragraph 0470; 0471; 0472
[3] Journal of Medicinal Chemistry, 2017, vol. 60, # 12, p. 4869 - 4881
METHYL 4-METHYL-3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)BENZOATESupplier
- Tel
- 0573-85285100 18627885956
- isenchem@163.com
- Tel
- 13526569071
- sales@leadmedpharm.com
- Tel
- 800-810-5118
- cnchemical@thermofisher.com
- Tel
- 021-58170097
- info@topbiochem.com
- Tel
- 150-2103-5486 18017383231
- 983544897@qq.com